In this study, the SEREX-defined (33% NY-SAR-35 and 30% NY-ESO-1) and the CTL-defined (42% MAGE-3 and 27% MAGE-1) antigens were the most frequently expressed in lung cancer tissues. This evidence concerns the gene MAGEA3 and lung carcinoma.